BioNeutra Global Stock

BioNeutra Global Liabilities

The The Liabilities of BioNeutra Global (BGA.V) as of Aug 23, 2026 is 21.96 M CAD. In the previous year, The Liabilities was 23.54 M CAD — a change of -6.70% (lower).

Liabilities

21.96 MCAD

YoY

-6.70%

Last updated:

In 2026, BioNeutra Global's total liabilities amounted to 21.96 M CAD, a -6.70% difference from the 23.54 M CAD total liabilities in the previous year.

The BioNeutra Global Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2016
20.81 M CAD
Jan 1, 2017
17.01 M CAD
Jan 1, 2018
21.93 M CAD
Jan 1, 2019
29.27 M CAD
Jan 1, 2020
22.98 M CAD
Jan 1, 2021
22.12 M CAD
Jan 1, 2022
23.54 M CAD
Jan 1, 2023
21.96 M CAD
The BioNeutra Global Liabilities history
YEARLiabilitiesYoY
21.96 MCAD-6.70%
23.54 MCAD+6.42%
22.12 MCAD-3.74%
22.98 MCAD-21.51%
29.27 MCAD+33.49%
21.93 MCAD+28.88%
17.01 MCAD-18.26%
20.81 MCAD+79.56%
11.59 MCAD+263.80%
3.19 MCAD—
Access this data via the Eulerpool API
Get Free API Key

BioNeutra Global Stock analysis

What does BioNeutra Global do? BioNeutra Global is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing BioNeutra Global's Liabilities

BioNeutra Global's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating BioNeutra Global's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing BioNeutra Global's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

BioNeutra Global's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in BioNeutra Global’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about BioNeutra Global stock

The Liabilities of BioNeutra Global is 21.96 M CAD in 2026.

The Liabilities of BioNeutra Global changed from 23.54 M CAD to 21.96 M CAD, representing a -6.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities BioNeutra Global since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's BioNeutra Global historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — BioNeutra Global

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — BioNeutra Global